- Home
- MCB vs BBOT Comparison
MCB vs BBOT Comparison
Compare MCB & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCB | BBOT |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.2M | 1.1B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MCB | BBOT |
|---|---|---|
| Price | $91.73 | $12.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $97.50 | $23.83 |
| AVG Volume (30 Days) | 185.2K | ★ 374.7K |
| Earning Date | 01-20-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.87% | N/A |
| EPS Growth | ★ 11.64 | N/A |
| EPS | ★ 6.62 | N/A |
| Revenue | ★ $277,514,000.00 | N/A |
| Revenue This Year | $29.07 | N/A |
| Revenue Next Year | $7.96 | N/A |
| P/E Ratio | $13.90 | ★ N/A |
| Revenue Growth | ★ 2.53 | N/A |
| 52 Week Low | $47.08 | $8.50 |
| 52 Week High | $96.75 | $14.87 |
Technical Indicators
Market Signals| Indicator | MCB | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 65.29 | 50.48 |
| Support Level | $87.74 | $10.88 |
| Resistance Level | $96.75 | $13.99 |
| Average True Range (ATR) | 3.62 | 0.85 |
| MACD | 0.70 | 0.09 |
| Stochastic Oscillator | 74.08 | 46.30 |
Price Performance
Historical ComparisonAbout MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.